genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2020
Astellas
Cancer
Astellas, CytomX Launch $1.7B Cancer Immunotherapy Collaboration
Cancer
Astellas Acquires Xyphos for Up to $665M, Boosting Cancer Immunotherapy Pipeline
Bioprocessing
Amid Multi-Billion-Dollar Deals, Panels Highlight Gene Therapy Challenges
Drug Discovery
Astellas to Acquire Audentes for $3B, Seeing Gene Therapy as “Key Driver”
Industry News
Astellas, Frequency Therapeutics Partner to Develop Hearing Loss Drug
Cancer
Astellas Acquires Collaboration Partner Potenza, Adding Cancer Immunotherapy Programs
Drug Discovery
Astellas Expands Its Eye Disorder Pipeline with Quethera Purchase
Drug Discovery
Aquinox Axes Half its Workforce after Phase III Failure of Lead Drug Rospitor
A-Lists
Top 20 Abused Prescription Drugs
Drug Discovery
Astellas Shutting Agensys Research Operations, Axing 220 Employees in Retreat from ADCs
1
2
3
4
...
13
Page 3 of 13
Scroll Up
Scroll Up
